Molex LLC, a global manufacturer of complete interconnect solutions, recently completed its acquisition of Phillips-Medisize Corp, a portfolio company of the San Francisco, California, based private equity investment firm, Golden Gate Capital. Phillips-Medisize will operate as an indirect subsidiary of Molex, LLC.
“Phillips-Medisize brings strong capabilities to Molex in the medical solutions market globally,” stated Martin Slark, Chief Executive Officer of Molex. “Combining Molex’s expertise in electronics and our broad manufacturing presence with Phillips-Medisize’s talented and experienced team will help us better serve the growing needs of the global market for innovative connected health solutions.”
“Phillips-Medisize is excited to be joining the Molex team and looks forward to the opportunities ahead,” said Matt Jennings, Chairman, President and CEO of Phillips-Medisize Corp.
Phillips-Medisize based in Hudson, Wisconsin, USA, started life injection moulding plastic components in the 1960s and today employs over 4,300 people in 17 production locations throughout the USA, Europe, Mexico and China. 85% of its approx. $700 million annual sales come from drug delivery, medical device and diagnostic products, such as disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single-use surgical devices and consumable diagnostic components. In December 2016 the company announced plans to open a new state-of-the-art 180,000 ft2 manufacturing facility at its Menomonie, Wisconsin, campus for the design and production of drug delivery devices.
Metal Injection Moulding was started at the company’s Menomonie plant in 1996 and in early 2016 work was completed on increasing the production capacity of the MIM facility to 50,000 ft2. It now houses four continuous debinding and sintering furnaces, multiple batch furnaces, dedicated Metal Injection Moulding machines and a fully equipped metallurgical laboratory.
One of the applications for Phillips-Medisize MIM components are the jaws for the award winning Novare Surgical RealHand High Dexterity instrument which is used in minimally invasive ‘hidden scar’ surgical techniques. In another MIM medical application, the design goal was to consolidate four parts into one in an oxygen regulator device used during surgery. The part, which contains the main body, a tube and two screws, was consolidated into one metal injection moulded part that also included moulded-in threads.